Search clinical trials for: AMD picasso

Total 271504 results

Columbia University
National Institute of Mental Health (NIMH)

Recruiting

Young Adults With Violent Behavior During Early Psychosis

Schizophrenia | Schizo Affective Disorder | Delusional Disorder | Schizophreniform Disorders | Other Specified Schizophrenia Spectrum and Other Psychotic Disorder

United States
Biosense Webster, Inc.

Completed

Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man

Arrhythmias

Czech Republic, Belgium
Bulent Ecevit University

Completed

Bacteria Elimination in Retreatment Cases Using Different Disinfection Techniques

Root Canal Infection | Periapical; Infection

Turkey
Duke University
National Institute of Nursing Research (NINR); National Institutes of Health...

Active, not recruiting

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions (PiCASO)

Chronic Kidney Diseases | Diabetes Mellitus, Type 1 | Systemic Lupus Erythematosus | Inflammatory Bowel Diseases | Cystic Fibrosis | Sickle Cell Disease | Stem Cell Transplant | Childhood Cancer | Organ Transplant

United States
LEO Pharma

Completed

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

Anogenital Warts

Denmark
Miracor Medical SA

Completed

Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention (PICSO)

Stable Angina

Netherlands
Center for Clinical Studies, Texas
LEO Pharma

Withdrawn

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

Molluscum Contagiosum

United States
Miracor Medical SA

Completed

PiCSO in ACS Study

Acute Coronary Syndrome

United Kingdom
Actavis Inc.

Completed

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

Actinic Keratosis

United States
Miracor Medical SA

Completed

PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention (pRAMSES)

ST Elevation (STEMI) Myocardial Infarction

Netherlands
LEO Pharma

Completed

The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice (PrAKtice)

Actinic Keratosis

Greece
Centre Hospitalier Universitaire de Nice

Completed

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face (PICAMEL)

Lentigo Maligna

France
Centre Hospitalier Universitaire de Nice

Completed

Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma (PICABAS)

Carcinoma

France
LEO Pharma

Completed

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

Actinic Keratosis

Germany
LEO Pharma

Completed

TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction (MIKADO)

Actinic Keratosis
Pacific Dermaesthetics
LEO Pharma

Unknown

Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis

Actinic Keratosis
Instituto Nacional de Cancer, Brazil

Withdrawn

Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment (EIMAC)

Actinic Cheilitis
Miracor Medical SA

Completed

Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction (PiCSO-AMI-I)

STEMI | Anterior MI

United Kingdom, Denmark, Latvia, France, Germany, Switzerland
Miracor Medical SA

Not yet recruiting

Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance (PiCSO-AMI-IV)

STEMI - ST Elevation Myocardial Infarction | Anterior MI

Germany
Oxford University Hospitals NHS Trust
Miracor Medical SA

Completed

Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion (OxAMI-PICSO)

ST Elevation Myocardial Infarction

United Kingdom
Oxford University Hospitals NHS Trust
Miracor Medical SA

Terminated

The Pressure-controlled Intermittent Coronary Sinus Occlusion on VentrIcular PERformance Study (PICSO-ViPER)

Myocardial Infarction

United Kingdom
Medical University of Vienna

Terminated

Evaluation of a Local Preconditioning Effect in Patients Undergoing Cardiac Surgery

Heart Disease | Coronary Artery Bypass Graft Triple Vessel

Austria
University of California, San Francisco

Completed

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Actinic Keratosis

United States
University of Campania "Luigi Vanvitelli"

Completed

Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy

Actinic Keratosis

Italy
Miracor Medical SA

Recruiting

A Study to Evaluate Safety and Feasibility of PiCSO Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction. (PiCSO-AMI-V)

Inferior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction

France, United Kingdom, Latvia, Switzerland, Denmark
Miracor Medical SA

Withdrawn

A Study to Evaluate the Safety and Efficacy of PiCSO in Anterior STEMI Patients (PiCSO-AMI-II)

Anterior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction
Skin Laser & Surgery Specialists
LEO Pharma

Completed

Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin

Actinic Keratosis | Photo-aged Skin
Neal D. Bhatia, MD
LEO Pharma

Completed

Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.

Verruca Vulgaris | Common Warts

United States
Günther Hofbauer

Terminated

Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses (IMOT001)

Actinic Keratosis

Switzerland
LEO Pharma

Completed

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States
LEO Pharma

Completed

A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities

Actinic Keratosis

Italy
Ramsay Générale de Santé
Assistance Publique - Hôpitaux de Paris; Faculty of Medicine Paris Saclay University and other collaborators

Recruiting

Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo Plateform (MULTIDOM)

Pancreas Cancer

France
Fundacio Privada Mon Clinic Barcelona
Miracor Medical SA

Not yet recruiting

Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute Microvascular Resistance by Continuous Thermodilution in ST-segment Elevation Myocardial Infarction (STEMI) Patients: PiCSO-STEMI TRIAL (PiCSO-STEMI)

Anterior Myocardial Infarction
LEO Pharma

Completed

PMS to Evaluate the Safety and Efficacy of Picato® Gel

Actinic Keratosis

Korea, Republic of
Korea University
Samsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaborators

Completed

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Actinic Keratosis

Korea, Republic of
Actavis Inc.

Completed

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

ACTINIC KERATOSIS

United States
University of Sao Paulo
LEO Pharma

Completed

Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis

Actinic Keratosis

Brazil
LEO Pharma

Completed

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

Actinic Keratosis

Australia
LEO Pharma

Completed

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Actinic Keratosis (AK)

Germany, United Kingdom, France
LEO Pharma

Completed

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Actinic Keratosis (AK)

Germany
Maastricht University Medical Center

Unknown

IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis (Akti)

Keratosis, Actinic

Netherlands
LEO Pharma

Completed

The Real Life Topical Field Treatment of Actinic Keratosis Study (RAPID-ACT)

Actinic Keratosis

Netherlands
Amgen

Terminated

Long-term Safety Study of Brodalumab in Adults With Crohn's Disease

Crohn's Disease

United States, France, Belgium, Australia, Netherlands, Spain, Canada, Poland
Osaka University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Age Related Macular Degeneration | Neovascular Maculopathy

Japan
Sun Yat-sen University

Not yet recruiting

Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma

Classic Hodgkin Lymphoma
UConn Health

Completed

Good Oral Health - A Bi-level Intervention to Improve Older Adult Oral Health

Gingivitis

United States
VA Office of Research and Development

Enrolling by invitation

Notched Noise Therapy for Suppression of Tinnitus

Tinnitus | Notched Noise Therapy

United States
Lawson Health Research Institute

Unknown

Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum

Obesity | Pregnancy | Wound Infection
Indiana University
National Institute of Nursing Research (NINR)

Completed

Equity Using Interventions for Pain and Depression - Pilot Study (EQUIPD-Pilot)

Depression | Chronic Pain | Health Equity

United States
European Cardiovascular Research Center
Comed B.V.

Unknown

Hyperion™ International Registry Trial (COM-01)

Patent Ductus Arteriosus | Atrial Septal Defects

France, Germany, Algeria, China

3

Subscribe